Guo Jun
Guo Jun — Chief Physician — Melanoma & Sarcoma — Peking University Cancer Hospital
Specialties
Engaged for a long time in clinical and translational medical research on melanoma, sarcoma, kidney cancer, bladder cancer, prostate cancer, and other skin and genitourinary tumors, gaining extensive clinical experience in personalized targeted therapy and biological immunotherapy.
Education
Graduated from the Second Military Medical University.
Professional Experience
Chief Physician, PhD Supervisor, Professor. Long engaged in clinical and translational medical research on skin and genitourinary tumors such as melanoma, sarcoma, kidney cancer, bladder cancer, and prostate cancer, with extensive clinical experience in individualized targeted therapy and biological immunotherapy. As a PI, led over 80 domestic registered studies and 13 international studies, promoting the approval of 13 anti-tumor new drugs by the National Medical Products Administration. As team leader/deputy leader, headed the organization and writing of three national guidelines: the "CSCO Melanoma Diagnosis and Treatment Guidelines," "CSCO Kidney Cancer Diagnosis and Treatment Guidelines," and "CSCO Urothelial Carcinoma Diagnosis and Treatment Guidelines." Pioneered international staging standards and new standards for adjuvant and first-line therapy for advanced mucosal melanoma, formulating more than 20 innovative treatment protocols. Research results have been frequently selected for oral presentations at ASCO and ESMO annual meetings, revised three international guidelines and five domestic diagnosis and treatment norms and guidelines, making significant contributions to the advancement of melanoma and genitourinary tumor diagnosis and treatment in China and internationally. Hosted over 10 national and provincial-level research projects, with research funding exceeding 70 million yuan.
Professional Roles
Vice Chairman and Secretary-General of the Chinese Society of Clinical Oncology (CSCO) Former Chairman of the CSCO Melanoma Expert Committee Deputy Chairman of the CSCO Kidney Cancer Expert Committee Deputy Chairman of the CSCO Immunotherapy Committee Deputy Chairman of the CSCO Urothelial Cancer Committee Deputy Chairman of the CSCO Prostate Cancer Committee Vice President of the Melanoma World Society (MWS) CFDA National Drug Registration Review Expert Member of the National Health and Family Planning Commission Rational Drug Use Expert Committee (Antitumor Drug Professional Group) Chairman of the National Cancer Center and National Oncology Quality Control Center Melanoma Committee